Interestingly, analysis of EZH2, the catalytic subunit of the PRC2 complex which acts to antagonize the SWI/SNF complex, indicated an increased expression in clear cell meningiomas compared to meningiomas with NF2 mutation (adjusted p = 1.70e-07; Suppl. Here, SMARCA1 is linked to meningioma.